ACTRN12611000800921尚未招募2 期
Fampridine treatment to improve fatigue in chronic inflammatory demyelinating polyneuropathy (CIDP).
niveristy of New South Wales0 个研究点目标入组 20 人开始时间: 2011年7月29日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Definitive diagnosis of CIDP
- •18-80 years of age.
- •Able to provide informed consent.
排除标准
- •History of seizures.
- •Current treatment with anticonvulsant medication.
- •Pregnancy or lactation. Contraception is required in pre-menopausal female patients.
- •History of moderate-severe renal impairment.
- •Presence of serious psychiatric disorder (e.g major depression, bipolar disorder)
- •Enrolled in another clinical trial involving an investigational agent.
- •Known allergy to pyridine-containing substances.
- •History of renal dysfunction, with eGFR <60 ml.
研究者
相似试验
已完成
2 期
Does Fampridine improve fatigue in patients with Multiple Sclerosis.ACTRN12611000799954niveristy of New South Wales25
招募中
不适用
Development of an intervention to treat fatigue in adults with a visual impairment.vision lossvisual disability (visual impairment)10047518NL-OMON42191Vrije Universiteit Medisch Centrum520
进行中（未招募）
1 期
Fampridine for treatment of functional disability in patients with immune mediated polyneuropathyMedDRA version: 20.0Level: LLTClassification code 10072650Term: CIDPSystem Organ Class: 100000004852Chronic inflammatory demyelinating polyneuropathyEUCTR2020-002438-34-DKDepartment of Neurology, Odense University Hospital40
尚未招募
Unknown
Effects of treatment on fatigue improvement for the purpose of recovery from fatigueJPRN-UMIN000053241ORTHOMEDICO Inc.300
已完成
不适用
Clinical Observation on the Treatment of Fatigued Crowd with Salt-separated Moxibustion with Bamboo RingSub-healthy fatigueITMCTR2100004235Guangdong Provincial Hospital of Traditional Chinese Medicine